Hepatitis Monthly

Published by: Kowsar
Uncorrected Proof scheduled for 19 (3)

Circulating Aflatoxin B1-Related TP53 Mutation Detected by Digital PCR in Tunisian Patients with and Without Hepatocellular Carcinoma

Agnes Marchio 1 , Ines Dhifallah 2 , Olfa Bahri 3 and Pascal Pineau 1 , *
Authors Information
1 Nuclear Organization and Oncogenes Unit, Pasteur Institute, Paris, France
2 Laboratory of Clinical Virology, Pasteur Institute of Tunis, Faculty of Sciences of Bizerte, University of Carthage, Tunis, Tunisia
3 Laboratory of Clinical Virology, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia
Article information
  • Hepatitis Monthly: In Press (In Press); e85775
  • Published Online: March 17, 2019
  • Article Type: Research Article
  • Received: October 26, 2018
  • Revised: January 15, 2019
  • Accepted: February 8, 2019
  • DOI: 10.5812/hepatmon.85775

To Cite: Marchio A, Dhifallah I, Bahri O, Pineau P. Circulating Aflatoxin B1-Related TP53 Mutation Detected by Digital PCR in Tunisian Patients with and Without Hepatocellular Carcinoma, Hepat Mon. Online ahead of Print ; In Press(In Press):e85775. doi: 10.5812/hepatmon.85775.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. J. Ferlay I, Soerjomataram M, Ervik R, Dikshit S, Eser C, Mathers M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base No. 11. Lyon, France: International Agency for Research on Cancer; 2013.
  • 2. Mokdad AH, Jaber S, Aziz MI, AlBuhairan F, AlGhaithi A, AlHamad NM, et al. The state of health in the Arab world, 1990-2010: An analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014;383(9914):309-20. doi: 10.1016/S0140-6736(13)62189-3. [PubMed: 24452042].
  • 3. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg. 1997;91(1):11-4. doi: 10.1016/S0035-9203(97)90374-6. [PubMed: 9093616].
  • 4. Mejri S, Salah AB, Triki H, Alaya NB, Djebbi A, Dellagi K. Contrasting patterns of hepatitis C virus infection in two regions from Tunisia. J Med Virol. 2005;76(2):185-93. doi: 10.1002/jmv.20342. [PubMed: 15834884].
  • 5. Ben Slama Trabelsi A, Ksiaa M, Souguir A, Issaoui D, Sriha B, Ajmi S. [Hepatic steatosis in chronic hepatitis B: Prevalence, risk factors, and impact on fibrosis and therapeutic response]. Tunis Med. 2013;91(7):431-4. French. [PubMed: 24008872].
  • 6. Hadidane R, Roger-Regnault C, Bouattour H, Ellouze F, Bacha H, Creppy EE, et al. Correlation between alimentary mycotoxin contamination and specific diseases. Hum Toxicol. 1985;4(5):491-501. doi: 10.1177/096032718500400505. [PubMed: 2997022].
  • 7. Abbes S, Salah-Abbes JB, Bouraoui Y, Oueslati S, Oueslati R. Natural occurrence of aflatoxins (B(1) and M(1)) in feed, plasma and raw milk of lactating dairy cows in Beja, Tunisia, using ELISA. Food Addit Contam Part B Surveill. 2012;5(1):11-5. doi: 10.1080/19393210.2011.640756. [PubMed: 24779689].
  • 8. Oueslati S, Romero-Gonzalez R, Lasram S, Frenich AG, Vidal JL. Multi-mycotoxin determination in cereals and derived products marketed in Tunisia using ultra-high performance liquid chromatography coupled to triple quadrupole mass spectrometry. Food Chem Toxicol. 2012;50(7):2376-81. doi: 10.1016/j.fct.2012.04.036. [PubMed: 22579994].
  • 9. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance. Mutat Res. 2007;635(2-3):105-17. doi: 10.1016/j.mrrev.2006.11.002. [PubMed: 17257890].
  • 10. Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet. 1991;338(8779):1356-9. doi: 10.1016/0140-6736(91)92236-U. [PubMed: 1682737].
  • 11. Gouas D, Shi H, Hainaut P. The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy. Cancer Lett. 2009;286(1):29-37. doi: 10.1016/j.canlet.2009.02.057. [PubMed: 19376640].
  • 12. Nault JC, Zucman-Rossi J. TERT promoter mutations in primary liver tumors. Clin Res Hepatol Gastroenterol. 2016;40(1):9-14. doi: 10.1016/j.clinre.2015.07.006. [PubMed: 26336998].
  • 13. Whale AS, Huggett JF, Cowen S, Speirs V, Shaw J, Ellison S, et al. Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res. 2012;40(11). e82. doi: 10.1093/nar/gks203. [PubMed: 22373922]. [PubMed Central: PMC3367212].
  • 14. Taly V, Pekin D, Benhaim L, Kotsopoulos SK, Le Corre D, Li X, et al. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin Chem. 2013;59(12):1722-31. doi: 10.1373/clinchem.2013.206359. [PubMed: 23938455].
  • 15. Debrand E, Lykoudi A, Bradshaw E, Allen SK. A non-invasive droplet digital PCR (ddPCR) assay to detect paternal CFTR mutations in the cell-free fetal DNA (cffDNA) of three pregnancies at risk of cystic fibrosis via compound heterozygosity. PLoS One. 2015;10(11). e0142729. doi: 10.1371/journal.pone.0142729. [PubMed: 26561302]. [PubMed Central: PMC4641687].
  • 16. Zhang BO, Xu CW, Shao Y, Wang HT, Wu YF, Song YY, et al. Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation. Exp Ther Med. 2015;9(4):1383-8. doi: 10.3892/etm.2015.2221. [PubMed: 25780439]. [PubMed Central: PMC4353752].
  • 17. Tang H, Cai Q, Li H, Hu P. Comparison of droplet digital PCR to real-time PCR for quantification of hepatitis B virus DNA. Biosci Biotechnol Biochem. 2016:1-6. doi: 10.1080/09168451.2016.1196576. [PubMed: 27310131].
  • 18. Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: Results from a nationwide survey. J Viral Hepat. 2012;19(8):560-7. doi: 10.1111/j.1365-2893.2011.01576.x. [PubMed: 22762140].
  • 19. Ezzikouri S, Pineau P, Benjelloun S. Hepatitis B virus in the Maghreb region: From epidemiology to prospective research. Liver Int. 2013;33(6):811-9. doi: 10.1111/liv.12135. [PubMed: 23530901].
  • 20. Ezzikouri S, Pineau P, Benjelloun S. Hepatitis C virus infection in the Maghreb region. J Med Virol. 2013;85(9):1542-9. doi: 10.1002/jmv.23643. [PubMed: 23780703].
  • 21. Musaiger AO. Overweight and obesity in eastern mediterranean region: Prevalence and possible causes. J Obes. 2011;2011:407237. doi: 10.1155/2011/407237. [PubMed: 21941635]. [PubMed Central: PMC3175401].
  • 22. Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl. 2004;10(2 Suppl 1):S69-73. doi: 10.1002/lt.20033. [PubMed: 14762843].
  • 23. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002;35(6):1485-93. doi: 10.1053/jhep.2002.33324. [PubMed: 12029634].
  • 24. Sartorius K, Sartorius B, Aldous C, Govender PS, Madiba TE. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiol. 2015;39(3):284-90. doi: 10.1016/j.canep.2015.04.006. [PubMed: 25922178].
  • 25. Hefaiedh R, Ennaifer R, Romdhane H, Ben Nejma H, Arfa N, Belhadj N, et al. Gender difference in patients with hepatocellular carcinoma. Tunis Med. 2013;91(8-9):505-8. [PubMed: 24227507].
  • 26. Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet. 2014;46(12):1267-73. doi: 10.1038/ng.3126. [PubMed: 25362482].
  • 27. Miller JD. Changing patterns of fungal toxins in crops: Challenges for analysts. J AOAC Int. 2016;99(4):837-41. doi: 10.5740/jaoacint.16-0110. [PubMed: 27455926].
  • 28. Uhlig S, Eriksen GS, Hofgaard IS, Krska R, Beltran E, Sulyok M. Faces of a changing climate: Semi-quantitative multi-mycotoxin analysis of grain grown in exceptional climatic conditions in Norway. Toxins (Basel). 2013;5(10):1682-97. doi: 10.3390/toxins5101682. [PubMed: 24084167]. [PubMed Central: PMC3813906].
  • 29. Boutrif E, Jemmali M, Campbell AD, Pohland AE. Aflatoxin in Tunisian foods and foodstuffs. Ann Nutr Aliment. 1977;31(4-6):431-4. [PubMed: 613907].
  • 30. Boutrif E, Jemmali M, Pohland AE, Campbell AD. Aflatoxin in Tunisian aleppo pine nuts. J Assoc Off Anal Chem. 1977;60(3):747-8. [PubMed: 870495].
  • 31. Ben Rejeb I, Arduini F, Arvinte A, Amine A, Gargouri M, Micheli L, et al. Development of a bio-electrochemical assay for AFB1 detection in olive oil. Biosens Bioelectron. 2009;24(7):1962-8. doi: 10.1016/j.bios.2008.10.002. [PubMed: 19026530].
  • 32. Bensassi F, Rhouma A, Ghrab M, Bacha H, Rabeh Hajlaoui M. Evaluation of cultivar susceptibility and storage periods towards aflatoxin B1 contamination on pistachio nuts. Mycotoxin Res. 2010;26(3):199-203. doi: 10.1007/s12550-010-0054-7. [PubMed: 23605384].
  • 33. Ghali R, Khlifa KH, Ghorbel H, Maaroufi K, Hedilli A. Aflatoxin determination in commonly consumed foods in Tunisia. J Sci Food Agric. 2010;90(14):2347-51. doi: 10.1002/jsfa.4069. [PubMed: 20812375].
  • 34. Jedidi I, Cruz A, Gonzalez-Jaen MT, Said S. Aflatoxins and ochratoxin A and their Aspergillus causal species in Tunisian cereals. Food Addit Contam Part B Surveill. 2017;10(1):51-8. doi: 10.1080/19393210.2016.1247917. [PubMed: 27735214].
  • 35. Fernández-Cruz ML, Mansilla ML, Tadeo JL. Mycotoxins in fruits and their processed products: Analysis, occurrence and health implications. J Adv Res. 2010;1(2):113-22. doi: 10.1016/j.jare.2010.03.002.
  • 36. Ozkan A, Bindak R, Erkmen O. Aflatoxin B(1) and aflatoxins in ground red chilli pepper after drying. Food Addit Contam Part B Surveill. 2015;8(3):227-33. doi: 10.1080/19393210.2015.1063014. [PubMed: 26099014].
  • 37. Hosny G, Farahat N, Tayel H, Hainaut P. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases. Cancer Lett. 2008;264(2):201-8. doi: 10.1016/j.canlet.2008.01.031. [PubMed: 18313840].
  • 38. El-Din HG, Ghafar NA, Saad NE, Aziz M, Rasheed D, Hassan EM. Relationship between codon 249 mutation in exon 7 of p53 gene and diagnosis of hepatocellular carcinoma. Arch Med Sci. 2010;6(3):348-55. doi: 10.5114/aoms.2010.14254. [PubMed: 22371770]. [PubMed Central: PMC3282511].
  • 39. Traore F, Gormally E, Villar S, Friesen MD, Groopman JD, Vernet G, et al. Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali. BMC Infect Dis. 2015;15:180. doi: 10.1186/s12879-015-0916-x. [PubMed: 25886382]. [PubMed Central: PMC4403772].
  • 40. Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr. 2004;80(5):1106-22. doi: 10.1093/ajcn/80.5.1106. [PubMed: 15531656].
  • 41. Khlangwiset P, Shephard GS, Wu F. Aflatoxins and growth impairment: A review. Crit Rev Toxicol. 2011;41(9):740-55. doi: 10.3109/10408444.2011.575766. [PubMed: 21711088].
  • 42. Lombard MJ. Mycotoxin exposure and infant and young child growth in Africa: What do we know? Ann Nutr Metab. 2014;64 Suppl 2:42-52. doi: 10.1159/000365126. [PubMed: 25341872].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments